The DSSk, named GlucoP, was designed to help patients in real-time while performing therapeutic corrective actions, including administration of insulin bolus to correct hyperglycemia or intake of carbohydrates in case of hypoglycemia.The glucose predictor is based on an artificial neural network trained with continuous glucose monitoring profiles. This evidence concerns the gene INS and Hypoglycemia.